KRIEGSMAN STEVEN A

CIK 00011974825 companiesWORCESTER, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001197482

Recent Transactions

50 trades

Exercise/Conversion
LadRx Corp$LADX
Common Stock, par value $0.001 per share
2020-08-07$0.26/sh+3,000,000→ 4,832,217 total
Tax Payment
LadRx Corp$LADX
Common Stock, par value $0.001 per share
2020-08-07$0.67/sh−1,164,179→ 3,668,038 total
Exercise/Conversion
LadRx Corp$LADX
Stock Option (right to buy)
2020-08-07−3,000,000→ 0 total
Award
LadRx Corp$LADX
Stock Option (right to buy)
2019-12-13+3,000,000→ 3,000,000 total
Award
LadRx Corp$LADX
CytRx Common Stock
2017-12-15$1.75/sh+387,597→ 387,597 total
Award
LadRx Corp$LADX
Stock Option (right to buy)
2017-12-15+208,334→ 208,334 total
Award
LadRx Corp$LADX
Stock Option (right to buy)
2016-12-15+1,250,000→ 1,250,000 total
Award
LadRx Corp$LADX
Stock Option (right to buy)
2016-12-15+1,250,000→ 1,250,000 total
Award
LadRx Corp$LADX
Common Stock
2016-12-15$0.43/sh+2,325,581→ 2,325,581 total
Award
LadRx Corp$LADX
Stock Option (right to buy)
2015-12-15+1,000,000→ 1,000,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (right to buy)
2015-06-19+100,000→ 100,000 total
Award
Ontrak, Inc.$OTRKQ
Stock Option to purchase Common Stock
2015-02-17+200,000→ 200,000 total
Award
LadRx Corp$LADX
Stock Option (right to buy)
2014-12-15+600,000→ 600,000 total
Sale
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2014-01-22$6.13/sh−250,000→ 5,000 total
Exercise/Conversion
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (right to buy)
2014-01-22−50,000→ 0 total
Exercise/Conversion
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2014-01-22$0.72/sh+50,000→ 255,000 total
Exercise/Conversion
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2014-01-22$1.18/sh+200,000→ 205,000 total
Exercise/Conversion
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (right to buy)
2014-01-22−200,000→ 0 total
Exercise/Conversion
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2014-01-17$0.85/sh+200,000→ 205,000 total
Sale
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2014-01-17$7.00/sh−200,000→ 5,000 total
Exercise/Conversion
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (right to buy)
2014-01-17−200,000→ 0 total
Award
LadRx Corp$LADX
Stock Option (right to buy)
2013-12-10+925,000→ 925,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (right to buy)
2013-11-26+200,000→ 200,000 total
Award
LadRx Corp$LADX
Stock Option (right to buy)
2013-03-08+74,176→ 74,176 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (right to buy)
2013-01-29+50,000→ 50,000 total
Award
LadRx Corp$LADX
Stock Option (right to buy)
2012-12-10+500,000→ 500,000 total
Purchase
LadRx Corp$LADX
Common Stock
2012-02-23$0.33/sh+105,517→ 4,179,776 total
Purchase
LadRx Corp$LADX
Common Stock
2012-02-22$0.31/sh+53,159→ 4,074,259 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (right to buy)
2012-01-12+50,000→ 50,000 total
Award
LadRx Corp$LADX
Stock Option (right to buy)
2011-12-12+1,500,000→ 1,500,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (right to buy)
2011-09-27+200,000→ 200,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option
2011-03-25+200,000→ 200,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option
2011-03-25+100,000→ 100,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option
2011-01-13+50,000→ 50,000 total
Award
LadRx Corp$LADX
Stock Option (right to buy)
2010-12-14+750,000→ 750,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option
2010-03-02+50,000→ 50,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option
2010-01-14+50,000→ 50,000 total
Award
LadRx Corp$LADX
Common Stock
2009-12-10+750,000→ 750,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2009-10-16+5,000→ 5,000 total
Sale
SELLAS Life Sciences Group, Inc.$SLS
Common
2009-08-19$3.13/sh−8,990→ 0 total
Sale
SELLAS Life Sciences Group, Inc.$SLS
Common
2009-07-02$4.19/sh−1,723→ 8,988 total
Disposition to Issuer
LadRx Corp$LADX
Stock Option (right to buy)
2009-07-01−450,000→ 0 total
Award
LadRx Corp$LADX
Stock Option (right to buy)
2009-07-01+350,000→ 350,000 total
Award
LadRx Corp$LADX
Stock Option (right to buy)
2009-07-01+250,000→ 250,000 total
Sale
SELLAS Life Sciences Group, Inc.$SLS
Common
2009-07-01$4.53/sh−1,170→ 10,711 total
Disposition to Issuer
LadRx Corp$LADX
Stock Option (right to buy)
2009-07-01−200,000→ 0 total
Award
LadRx Corp$LADX
Stock Option (right to buy)
2009-07-01+200,000→ 200,000 total
Award
LadRx Corp$LADX
Stock Option (right to buy)
2009-07-01+750,000→ 750,000 total
Disposition to Issuer
LadRx Corp$LADX
Stock Option (right to buy)
2009-07-01−350,000→ 0 total
Disposition to Issuer
LadRx Corp$LADX
Stock Option (right to buy)
2009-07-01−750,000→ 0 total

Companies

Recent Filings

Address

C/O RXI PHARMACEUTICALS CORPORATION 60 PRESCOTT STREET

WORCESTER, MA, 01605

View on SEC.gov